85
Proceed with
cardioversion
on therapeutic
anticoagulation
(1)
Proceed with
cardioversion
on therapeutic
anticoagulation
(1)
For patients with
low thromboembolic
risks and AF duration
<12 h, the role of
pericardioversion
thromboembolic
evaluation or
prophylaxis is uncertain
(2b)
≥3 wk duration of therapeutic
anticoagulation prior to
cardioversion or precardioversion
imaging to exclude intracardiac
thrombus before cardioversion
(1)
On AC
Precardioversion
imaging evaluation to
exclude intracardiac
thrombus
(1)
Does
imaging show
intracardiac
thrombus?
YES
NO
Uninterrupted
therapeutic anticoagulation
≥3 wk confirmed?
YES
YES
YES
NO
NO
NO
NO
AF duration
<48 h
Even when reported AF
<48 h, consider imaging
evaluation to exclude
intracardiac thrombus
(2b)
Is this a patient
of elevated
thromboembolic
risks?
